# FDA recall D-1055-2014

> **Fusion Pharmaceuticals, LLC** · Class II · drug recall initiated 2013-05-08.

## Product

Dicopanol FusePaq Kit for Oral Suspension, 5mg/ML

## Reason for recall

Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopanol FusePaq Kit due to Total Yeasts and Molds Count above USP limits.

## Distribution

CA

## Key facts

- **Recall number:** D-1055-2014
- **Recalling firm:** Fusion Pharmaceuticals, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-05-08
- **Report date:** 2014-02-12
- **Termination date:** 2014-01-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Camarillo, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1055-2014

## Citation

> AI Analytics. FDA recall D-1055-2014. Retrieved 2026-06-03 from https://api.ai-analytics.org/recall/D-1055-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*